Health Catalyst (HCAT)
(Delayed Data from NSDQ)
$7.15 USD
+0.10 (1.42%)
Updated Aug 21, 2024 04:00 PM ET
After-Market: $7.16 +0.01 (0.14%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Balance Sheet
Fiscal Year End for Health Catalyst, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 318 | 363 | 445 | 271 | 228 |
Receivables | 60 | 48 | 49 | 48 | 28 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 15 | 16 | 15 | 11 | 8 |
Total Current Assets | 393 | 428 | 508 | 330 | 264 |
Net Property & Equipment | 26 | 26 | 23 | 13 | 4 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 264 | 278 | 275 | 207 | 29 |
Deposits & Other Assets | 5 | 4 | 5 | 4 | 1 |
Total Assets | 702 | 752 | 832 | 578 | 302 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 7 | 4 | 5 | 5 | 4 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 23 | 20 | 24 | 17 | 9 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 56 | 55 | 61 | 64 | 33 |
Total Current Liabilities | 89 | 83 | 93 | 88 | 48 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 1 | 2 | 1 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 228 | 227 | 181 | 169 | 48 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 15 | 19 | 2 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 335 | 327 | 310 | 302 | 102 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1,484 | 1,425 | 0 | 0 | 0 |
Capital Surplus | 0 | 0 | 1,401 | 1,002 | 811 |
Retained Earnings | -1,117 | -999 | -879 | -726 | -611 |
Other Equity | 0 | -1 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 367 | 425 | 522 | 276 | 201 |
Total Liabilities & Shareholder's Equity | 702 | 752 | 832 | 578 | 302 |
Total Common Equity | 367 | 425 | 522 | 276 | 201 |
Shares Outstanding | 57.50 | 54.70 | 52.00 | 42.50 | 36.50 |
Book Value Per Share | 6.38 | 7.77 | 10.04 | 6.50 | 5.50 |
Fiscal Year End for Health Catalyst, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 308 | 328 | 318 | 348 | 344 |
Receivables | 55 | 54 | 60 | 46 | 52 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 13 | 15 | 15 | 15 | 15 |
Total Current Assets | 376 | 397 | 393 | 408 | 411 |
Net Property & Equipment | 26 | 25 | 26 | 26 | 26 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 273 | 257 | 264 | 258 | 265 |
Deposits & Other Assets | 5 | 4 | 5 | 5 | 5 |
Total Assets | 692 | 695 | 702 | 713 | 723 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 11 | 6 | 7 | 6 | 8 |
Current Portion Long-Term Debt | 229 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 18 | 20 | 23 | 21 | 16 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 57 | 64 | 56 | 53 | 60 |
Total Current Liabilities | 318 | 92 | 89 | 84 | 87 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 228 | 228 | 227 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 335 | 338 | 335 | 331 | 333 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1,508 | 1,495 | 1,484 | 1,469 | 1,455 |
Capital Surplus | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | -1,151 | -1,138 | -1,117 | -1,087 | -1,065 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 357 | 357 | 367 | 382 | 390 |
Total Liabilities & Shareholder's Equity | 692 | 695 | 702 | 713 | 723 |
Total Common Equity | 357 | 357 | 367 | 382 | 390 |
Shares Outstanding | 59.00 | 59.00 | 57.50 | 56.90 | 56.20 |
Book Value Per Share | 6.05 | 6.05 | 6.38 | 6.72 | 6.94 |